Loading…
CIK 0001958125 • 7 13F filings • May 15, 2025 – Sep 2, 2026
Import this data to Google Sheets with:
=jivedata("catalio-capital-management-lp","13f")Uses this filer's slug. Install the Jive Data add-on first; the second argument is "13f".
Past 5 quarters
| % of Portfolio | |||||
|---|---|---|---|---|---|
| 4D MOLECULAR THERAPEUTICS IN | COM | $6.3M | 1.2% | 471,254 SH | New |
| ASCENDIS PHARMA A/S | ORD SHS | $8.5M | 1.6% | 31,759 SH | New |
| ATAIBECKLEY INC | COM SHS | $1.0M | 0.2% | 196,858 SH | New |
| AVALYN PHARMACEUTICALS INC | COM SHS | $55.2M | 10.4% | 1,675,830 SH | New |
| AXSOME THERAPEUTICS INC. | COM | $10.6M | 2.0% | 43,182 SH | New |
| BRIDGEBIO ONCOLOGY THERAPEUT | COM NEW | $2.4M | 0.5% | 318,407 SH | New |
| BRIDGEBIO PHARMA INC | COM | $33.9M | 6.4%Prev: 8.4% | 455,041 SH | Decreased-472,670 SH |
| BRISTOL-MYERS SQUIBB CO | COM | $23.8M | 4.5% | 412,961 SH | New |
| CORVUS PHARMACEUTICALS INC | COM | $16.1M | 3.0% | 1,080,888 SH | New |
| DEFINIUM THERAPEUTICS INC | COM SHS | $26.5M | 5.0% | 562,672 SH | New |
| DIANTHUS THERAPEUTICS INC | COM | $3.2M | 0.6%Prev: 2.9% | 32,941 SH | Decreased-713,586 SH |
| DISC MEDICINE INC | COM | $11.7M | 2.2%Prev: 0.3% | 159,384 SH | Increased+128,723 SH |
| DYNE THERAPEUTICS INC | COM | $5.4M | 1.0% | 244,929 SH | New |
| EDWARDS LIFESCIENCES CORP | COM | $11.3M | 2.1%Prev: 6.4% | 124,778 SH | Decreased-266,154 SH |
| ELEDON PHARMACEUTICALS INC | COM | $6.7M | 1.3% | 1,695,071 SH | New |
| FAETH THERAPEUTICS INC | COM NEW | $368K | 0.1% | 14,718 SH | New |
| FRACTYL HEALTH INC | COM | $4.9M | 0.9%Prev: 0.1% | 6,168,749 SH | Increased+5,954,513 SH |
| GILEAD SCIENCES INC | COM | $34.0M | 6.4%Prev: 5.3% | 269,309 SH | Increased+42,434 SH |
| HEARTFLOW INC | COM | $17.1M | 3.2% | 583,055 SH | New |
| HYPERFINE INC | COM CL A | $1.8M | 0.3%Prev: 0.1% | 1,320,041 SH | Increased+560,006 SH |
| IMMUNOCORE HLDGS PLC | ADS | $4.7M | 0.9% | 148,045 SH | New |
| INCYTE CORP | COM | $21.7M | 4.1% | 191,627 SH | New |
| JOHNSON & JOHNSON | COM | $35.3M | 6.6% | 138,946 SH | New |
| KAILERA THERAPEUTICS INC | COMMON STOCK | $10.3M | 1.9% | 468,750 SH | New |
| KARDIGAN INC | COM | $7.5M | 1.4% | 312,500 SH | New |
| KARYOPHARM THERAPEUTICS INC | COM NEW | $9.2M | 1.7%Prev: 0.1% | 940,855 SH | Increased+794,842 SH |
| METAGENOMI THERAPEUTICS INC | COM | $630K | 0.1% | 528,993 SH | New |
| MINERALYS THERAPEUTICS INC | COM | $17.5M | 3.3% | 648,722 SH | New |
| NATERA INC | COM | $22.3M | 4.2%Prev: 3.4% | 82,181 SH | Increased-15,116 SH |
| ODYSSEY THERAPEUTICS INC | COMMON STOCK | $8.6M | 1.6% | 457,839 SH | New |
| OUTSET MED INC | COM NEW | $511K | 0.1%Prev: 0.7% | 118,279 SH | Decreased-48,387 SH |
| PARABILIS MEDICINES INC | COM | $22.6M | 4.2% | 824,043 SH | New |
| PROTAGONIST THERAPEUTICS INC | COM | $13.1M | 2.5% | 106,799 SH | New |
| PROTARA THERAPEUTICS INC | COM STK | $2.0M | 0.4%Prev: 1.0% | 520,148 SH | Decreased-1,106,222 SH |
| SEPTERNA INC | COM | $18.0M | 3.4%Prev: 0.7% | 536,152 SH | Increased+241,792 SH |
| STRUCTURE THERAPEUTICS INC | SPONSORED ADS | $14.8M | 2.8%Prev: 2.9% | 276,550 SH | Increased-394,025 SH |
| SYNDAX PHARMACEUTICALS INC | COM | $26.6M | 5.0%Prev: 4.1% | 1,215,698 SH | Increased-888,814 SH |
| ULTRAGENYX PHARMACEUTICAL IN | COM | $10.6M | 2.0%Prev: 1.6% | 316,252 SH | Increased+102,850 SH |
| VERADERMICS INC | COMMON STOCK | $5.6M | 1.1% | 45,856 SH | New |
| 13F-HR |
| 0001958125-26-000005 |
| $532.1M |
| View |
| Aug 14, 2025 | Q2 2025 | 13F-HR | 0001958125-25-000007 | $476.9M | View |
| May 15, 2026 | Q1 2026 | 13F-HR | 0001958125-26-000003 | $478.7M | View |
| May 15, 2025 | Q1 2025 | 13F-HR | 0001958125-25-000004 | $411.1M | View |